How to Get Contrave Online (2026): The Oral Naltrexone-Bupropion Pathways & Cost

If you have read about GLP-1 shots like Wegovy and Zepbound and wondered whether there is an oral, non-injectable prescription weight-loss option, Contrave is one of the most common answers. Contrave is an FDA-approved pill — not a GLP-1 — that combines two old, well-characterized drugs: naltrexone (used for opioid and alcohol dependence) and bupropion (an antidepressant and smoking-cessation aid). The FDA approved it on September 10, 2014 for chronic weight management in adults with obesity or overweight plus a weight-related condition.^[1][2] It works on the brain's appetite and reward pathways to reduce hunger and food cravings. It also carries a boxed warning — the FDA's strongest — for suicidal thoughts and behaviors, because bupropion is an antidepressant-class drug.^[2] This guide explains what Contrave actually is, who it suits and who must avoid it, the legitimate online pathways, what each costs in 2026, how to verify a telehealth provider, and the safety facts you should not skip. See our medications overview and our ranking of the best semaglutide providers if you are weighing Contrave against a GLP-1.

What Contrave actually is — and what it's FDA-approved for

Contrave is an oral, twice-daily extended-release tablet that combines two active ingredients: naltrexone HCl 8 mg and bupropion HCl 90 mg per tablet.^[2] Naltrexone is an opioid antagonist used to treat alcohol and opioid dependence; bupropion is an aminoketone antidepressant also marketed for smoking cessation. Combined, they act on two brain systems involved in eating: the hypothalamus (which regulates appetite) and the mesolimbic dopamine reward circuit (which drives food cravings). The result is reduced hunger and fewer cravings — Contrave does not block fat absorption or mimic a gut hormone.

The FDA approved Contrave on September 10, 2014 as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) of 30 kg/m² or greater (obesity), or 27 kg/m² or greater (overweight) in the presence of at least one weight-related condition such as hypertension, type 2 diabetes, or dyslipidemia.^[1][2] It is titrated gradually: starting at one tablet each morning, the dose steps up over four weeks to the maintenance dose of two tablets twice daily — a total of 32 mg naltrexone / 360 mg bupropion per day.^[2] The slow titration is deliberate; it reduces nausea and other side effects.

Who Contrave suits — and who should avoid it

Contrave can be a reasonable option for adults who meet the BMI criteria, want an oral alternative to injectable GLP-1s, and especially for people whose eating is driven by cravings and emotional or reward-based eating — the reward-circuit mechanism is where Contrave is theoretically well matched. Some prescribers also consider it for patients who also want help with smoking cessation or low mood, given the bupropion component (though Contrave is not approved to treat depression or for smoking cessation). It is a once-you-qualify, prescriber-evaluated decision — not something to self-select.

Contrave is contraindicated — meaning it should not be used at all — in a number of situations. A legitimate prescriber screens for every one of these:

• Uncontrolled hypertension. Bupropion can raise blood pressure and heart rate; Contrave is contraindicated in uncontrolled high blood pressure.^[2]
• Seizure disorder, or any condition that lowers the seizure threshold. Bupropion is associated with a dose-dependent risk of seizures; Contrave is contraindicated in patients with a seizure disorder, and in those with a history of bulimia or anorexia nervosa or who are undergoing abrupt discontinuation of alcohol, benzodiazepines, barbiturates, or antiepileptic drugs.^[2]
• Chronic opioid use. Because Contrave contains the opioid antagonist naltrexone, it is contraindicated in patients on chronic opioids or opioid agonists (e.g., methadone) or in acute opioid withdrawal.^[2]
• Pregnancy. Weight loss offers no benefit during pregnancy and may harm the fetus; Contrave should be discontinued if pregnancy occurs.^[2]
• Eating disorders. A current or prior diagnosis of bulimia or anorexia nervosa is a contraindication (higher seizure risk).^[2]
• Use of MAO inhibitors within the prior 14 days, and known allergy to bupropion, naltrexone, or any component.^[2]

This list is not exhaustive — the boxed warning for suicidal thoughts and behaviors applies to everyone, and patients with a history of depression or other psychiatric conditions need careful monitoring. The point of a legitimate intake (in person or via telehealth) is to surface these before a prescription is written.

The legitimate online pathways

Contrave is a prescription-only medication, so every legitimate route involves a licensed prescriber. There are three practical online pathways in 2026 — none of them involves buying Contrave without a prescription.

Pathway 1: Insurance + manufacturer CurAccess / savings program

If you have commercial insurance that covers anti-obesity medications, Contrave may be partially or fully covered after your prescriber documents that you meet the BMI criteria (a prior authorization is common). The manufacturer, Currax Pharmaceuticals, runs CurAccess, a direct-to-patient program, alongside a commercial savings offer; eligible commercially-insured patients can often reduce their out-of-pocket cost substantially, and there is a cash/telehealth channel for those without coverage. Savings offers typically exclude Medicare, Medicaid, and other government plans. Your prescriber sends the prescription to a participating pharmacy and you fill it like any other covered medication. This is usually the lowest-cost path if your plan covers weight-loss drugs.

Pathway 2: Telehealth prescriber + brand or authorized generic

The dominant online route. A telehealth platform connects you with a clinician licensed in your state; you complete a medical intake and a (synchronous or asynchronous) visit; the clinician evaluates eligibility — checking the contraindications above — and, if appropriate, prescribes Contrave. Neither naltrexone nor bupropion is a DEA-scheduled controlled substance, so the in-person-evaluation rules that apply to drugs like phentermine do not apply here, and telehealth-only prescribing of Contrave is permitted subject to state law. The prescription may be filled as brand Contrave or, where available, an authorized generic naltrexone/bupropion ER, which can lower the cash price. General-purpose telehealth providers such as Found, Ro, and Hims operate weight-management programs on this model.

Pathway 3: Cash-pay direct (CurAccess or telehealth cash channel)

For people without weight-loss-drug coverage, the cash-pay route — either through the manufacturer's direct CurAccess channel or a telehealth platform's self-pay program — is common. Cash pricing for brand Contrave is often in the $99-$150/month range through these programs, well below the undiscounted retail price, and an authorized generic (where a platform offers it) can be lower still. Unlike compounded GLP-1s, there is no “compounded Contrave” gray market to worry about — but you should still verify the prescriber and pharmacy (next section).

What it costs (2026)

Monthly cost varies widely by pathway. The table below uses representative 2026 figures; insured cost depends on your plan's formulary, deductible, and whether anti-obesity drugs are covered at all, and cash pricing varies by program and pharmacy.

Many people weigh Contrave against an injectable GLP-1 on both cost and expected results. GLP-1s tend to produce larger average weight loss but cost more and require injections; Contrave is oral and often cheaper but typically delivers more modest results. If you are running that comparison, the table below shows verified GLP-1 telehealth providers side by side.

How to verify a telehealth provider is legitimate

Contrave is not a controlled substance, but a legitimate online pathway still has to clear basic medical and pharmacy checks — and because of the boxed warning and the contraindication list, the medical intake matters more here than for many other medications. Five independent verifications; a trustworthy provider passes all five:

1. LegitScript certification. LegitScript is a third-party service that certifies online healthcare merchants and pharmacies as compliant with applicable law. It is voluntary — absence is not disqualifying — but its presence means the merchant passed a real compliance review. Verify at legitscript.com/searches/healthcare.
2. Licensed prescriber in YOUR state. A real clinician — physician, NP, or PA — must be licensed in the state where you live, not just somewhere in the US. The platform should disclose who is prescribing; verify the license through your state medical (or nursing) board.
3. Licensed dispensing pharmacy. Brand Contrave and its authorized generic come from FDA-approved manufacturers, but the dispensing pharmacy should still be state-licensed. Ask which pharmacy fills the prescription and confirm via the state board of pharmacy or the NABP .pharmacy verified-websites program.
4. A real medical intake that screens for contraindications. A legitimate platform asks about blood pressure, seizure history, opioid use, pregnancy/breastfeeding, eating-disorder history, current antidepressants/MAOIs, and especially mental-health history given the boxed warning. A site that prescribes Contrave with no health screening is a serious red flag.
5. Follow-up and monitoring. Because of the boxed warning for suicidal thoughts and the blood-pressure effect, a legitimate provider should plan follow-up — checking mood and blood pressure during titration and the first months. A “one-and-done” prescription with no follow-up is a warning sign.

Red flags, YMYL safety, and the boxed warning

Contrave is a real medication with real risks. The boxed warning for suicidal thoughts and behaviors is the single most important safety fact: anyone starting Contrave should be monitored for new or worsening depression and unusual changes in mood or behavior, especially early in treatment and after dose changes, and should stop and contact a prescriber if these occur.^[2] No legitimate provider minimizes this. Walk away from any source showing these patterns:

• “Contrave without a prescription” or “no consultation required.” There is no legitimate no-prescription pathway for Contrave in the US. A site selling it without a prescriber is operating illegally.
• No mental-health or contraindication screening. Given the boxed warning and the seizure/hypertension/opioid contraindications, a platform that skips this screening is unsafe and likely illegitimate.
• Foreign mail-order “Contrave” at far-below-market prices, or unbranded naltrexone/bupropion from gray-market sources with no named pharmacy or prescriber.
• Dosing that ignores titration. Contrave is deliberately titrated over four weeks to two tablets twice daily; a source that pushes the full dose from day one, or non-standard dosing, is ignoring the label and raising the seizure and side-effect risk.^[2]
• Claims it treats depression or is “safe for everyone.” Contrave is not approved to treat depression, and it is contraindicated in several conditions; any blanket safety claim is false.

Common side effects of Contrave are gastrointestinal and neurologic — nausea, constipation, headache, vomiting, dizziness, insomnia, and dry mouth — and many ease with the slow titration.^[2] More serious considerations include the seizure risk (dose-dependent, from the bupropion component), increases in blood pressure and heart rate, and the boxed warning for suicidal thoughts. None of this is a reason to fear the drug for someone who qualifies; it is a reason to obtain it through a real prescriber who screens you, titrates you, and follows up — exactly what the legitimate pathways above are built to do.